MEDTRONIC PUERTO RICO OPERATIONS CO. SYNCHROMED II; PUMP, INFUSION, IMPLANTED, PROGRAMMABLE
|
Back to Search Results |
|
Model Number 8637-40 |
Device Problem
Insufficient Flow or Under Infusion (2182)
|
Patient Problems
Bruise/Contusion (1754); Fall (1848); Itching Sensation (1943); Muscle Weakness (1967); Muscular Rigidity (1968); Distress (2329); Complaint, Ill-Defined (2331); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
|
Event Date 03/17/2020 |
Event Type
Injury
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Information was received from a consumer via a device manufacturer representative regarding a patient receiving lioresal (2000 mcg/ml at 183.5 mcg/day) via an implantable infusion pump.It was reported that the patient's pump was being replaced on (b)(6) 2020 due to issues since the implant of the pump on (b)(6) 2020.The patient reported that their previous pump worked predictably, but their new one "failed due to workmanship." they reported that their legs would be rigid, then the next day too weak to hold them up.They also experienced severe itching and three falls which necessitated emergency medical service calls to the house.The patient had to "go on hospice" because he could no longer shower or transfer to his wheelchair by himself.During one fall, his toenail was torn off.Another fall caused an injury to his hand.The added stress has caused a worsening of his motor neuron disease, including more slurred speech.He was also bruised from the falls.During a refill, 20.2ml of medication was expected, but 34ml was removed.The pump was going to be returned for analysis.No further complications were reported.
|
|
Manufacturer Narrative
|
H3: analysis of the pump revealed no significant anomaly; pump exterior- impact dents-did not affect post-explant performance.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|